New Times,
New Thinking.

  1. Politics
19 August 2010

In this week’s New Statesman: Pakistan special

William Dalrymple: The military and the mullahs | Ed Miliband interview | John Pilger: Why we must d

By George Eaton

This week’s New Statesman is a special issue devoted to the world’s most dangerous country — Pakistan. In our lead essay, William Dalrymple looks at how the country’s history of nurturing jihadis as a means of survival is beginning to backfire.

Elsewhere, Fatima Bhutto denounces Pakistan’s political elite for abandoning the nation in its hour of need and Samira Shackle reports from Bradford on the uncertain future facing the city’s Mirpuri community.

Also, don’t miss a revealing interview with Imran Khan and an exclusive short story from Aamer Hussein.

In British politics, the Labour leadership candidate Ed Miliband tells Jason Cowley and Mehdi Hasan that he won’t be defined by the right-wing press and reveals, for the first time, that he would never work with Nick Clegg. Meanwhile, ahead of this weekend’s Australian election, the Labour MP Caroline Flint asks why Britain has no Julia Gillard of its own.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

All this, plus John Pilger on why we must defend WikiLeaks, David Blanchflower on the growing risk of a double-dip recession and Maurice Glasman on how the Tories stole Labour’s language.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines